EUVIMEDEUVIMED entdecken
Open Access

RNF125 inhibits EMT and glycolysis in breast cancer by suppressing HDAC1-mediated histone deacetylation of PGM5

Yanhong Wei, Zhaohui Tang, Pengfei Luo, Yongjian Chen, Zuneng He, Zhangwen Tang, Lin Liao, Fang Li, Xuanye Ouyang, Ming Wu, Shaohui Jiang, Sijuan Ding

Epigenomics · 03.07.2026 · 18 (7) · 791-803

DOI: 10.1080/17501911.2026.2696955 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, online erschienen am 14.07.2026. Verfasst von Yanhong Wei und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yongzhou Central Hospital, Yongzhou, Hunan, China. Hauptthemen laut MEDLINE: Histone Deacetylase 1, Glycolysis, Epithelial-Mesenchymal Transition, Breast Neoplasms. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Hunan Provincial Natural Science Foundation Regional Joint Fund, 2025 Yongzhou Guiding Science and Technology Program Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Histone Deacetylase 1GlycolysisEpithelial-Mesenchymal TransitionBreast NeoplasmsUbiquitin-Protein LigasesHistonesPhosphoglycerate MutaseHumansFemaleAnimalsMiceCell Line, TumorGene Expression Regulation, NeoplasticAcetylationPromoter Regions, Genetic

Stichwörter der Autor:innen

HDAC1PGM5RNF125breast cancerglycolysis

Substanzen

Histone Deacetylase 1Ubiquitin-Protein LigasesHistonesHDAC1 protein, humanPhosphoglycerate Mutase

Autor:innen und Institutionen

  • Department of Oncology, Yongzhou Central Hospital, Yongzhou, Hunan, China.
  • Yongzhou Central Hospital, Yongzhou, Hunan, China.
  • Department of Otorhinolaryngology Head and Neck Surgery, Yongzhou Central Hospital, Yongzhou, Hunan, China.
  • Department of Anesthesiology, Yongzhou Central Hospital, Yongzhou, Hunan, China.

Förderung

  • Hunan Provincial Natural Science Foundation Regional Joint Fund
  • 2025 Yongzhou Guiding Science and Technology Program Project

Zitieren

APA

Wei, Y., Tang, Z., Luo, P., Chen, Y., He, Z., Tang, Z., Liao, L., Li, F., Ouyang, X., Wu, M., Jiang, S., & Ding, S. (2026). RNF125 inhibits EMT and glycolysis in breast cancer by suppressing HDAC1-mediated histone deacetylation of PGM5. Epigenomics, 18(7), 791-803. https://doi.org/10.1080/17501911.2026.2696955

Vancouver

Wei Y, Tang Z, Luo P, Chen Y, He Z, Tang Z, et al. RNF125 inhibits EMT and glycolysis in breast cancer by suppressing HDAC1-mediated histone deacetylation of PGM5. Epigenomics. 2026;18(7):791-803. doi:10.1080/17501911.2026.2696955

BibTeX
@article{Wei2026,
  author = {Wei, Yanhong and Tang, Zhaohui and Luo, Pengfei and Chen, Yongjian and He, Zuneng and Tang, Zhangwen and Liao, Lin and Li, Fang and Ouyang, Xuanye and Wu, Ming and Jiang, Shaohui and Ding, Sijuan},
  title = {RNF125 inhibits EMT and glycolysis in breast cancer by suppressing HDAC1-mediated histone deacetylation of PGM5},
  journal = {Epigenomics},
  year = {2026},
  volume = {18},
  number = {7},
  pages = {791--803},
  doi = {10.1080/17501911.2026.2696955}
}
Kostenlos starten →